Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiofrequency ablation for patients with refractory or advanced lung cancer and related thoracic malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lung Cancer
• Malignant Mesothelioma
• Thymoma and Thymic Carcinoma

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Cancer, Malignant Mesothelioma | Phase 2 | Status: COMPLETED